Exelixis Inc [EXEL] stock prices are down -1.66% to $22.49 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The EXEL shares have lost -0.71% over the last week, with a monthly amount drifted -4.18%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Exelixis Inc [NASDAQ: EXEL] stock has seen the most recent analyst activity on April 11, 2024, when Barclays downgraded its rating to a Equal Weight but kept the price target unchanged to $25 for it. Previously, BTIG Research started tracking the stock with Buy rating on December 19, 2023, and set its price target to $27. On December 15, 2023, Citigroup initiated with a Buy rating and assigned a price target of $31 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $28 on September 26, 2023. Oppenheimer reiterated its recommendation of a Outperform and raised its price target to $29 on August 22, 2023. SVB Securities started tracking with a Market Perform rating for this stock on August 08, 2023, and assigned it a price target of $18.
The stock price of Exelixis Inc [EXEL] has been fluctuating between $18.08 and $24.34 over the past year. Currently, Wall Street analysts expect the stock to reach $25.8 within the next 12 months. Exelixis Inc [NASDAQ: EXEL] shares were valued at $22.49 at the most recent close of the market. An investor can expect a potential return of 14.72% based on the average EXEL price forecast.
Analyzing the EXEL fundamentals
The Exelixis Inc [NASDAQ:EXEL] reported sales of 1.83B for trailing twelve months, representing a surge of 13.15%. Gross Profit Margin for this corporation currently stands at 0.96% with Operating Profit Margin at 0.09%, Pretax Profit Margin comes in at 0.14%, and Net Profit Margin reading is 0.11%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.09 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 22.22 points at the first support level, and at 21.96 for the second support level. However, for the 1st resistance point, the stock is sitting at 22.99, and for the 2nd resistance point, it is at 23.49.
Ratios To Look Out For
It’s worth pointing out that Exelixis Inc [NASDAQ:EXEL]’s Current Ratio is 3.34. Also, the Quick Ratio is 3.30, while the Cash Ratio stands at 0.67. Considering the valuation of this stock, the price to sales ratio is 3.73, the price to book ratio is 3.01 and price to earnings (TTM) ratio is 34.75.
Transactions by insiders
Recent insider trading involved Garber Alan M, Director, that happened on Mar 21 ’24 when 19205.0 shares were sold. EVP, Commercial, Haley Patrick J. completed a deal on Feb 23 ’24 to sell 47020.0 shares. Meanwhile, Director JOHNSON DAVID EDWARD bought 0.19 million shares on Feb 21 ’24.
